SACRAMENTO, Calif., Dec. 17, 2013 (GLOBE NEWSWIRE) -- NVN Therapeutics (www.nvnth.com) today introduced a new tropical flavor Glucorein™ Medical Food for the Dietary Management of PCOS. Patent-pending Glucorein™ for Polycystic Ovary Syndrome (PCOS) contains a proprietary blend of chlorogenic acid and L-cysteine, which collectively reduces the incidence of metabolic syndrome and insulin resistance, both thought to be key contributors to PCOS. Both the new tropical flavor Glucorein™ for PCOS, as well as the original (natural cranberry and lemon beverage), are to be used under the supervision of a medical professional.
PCOS produces symptoms in up to 10% of women of reproductive age (12-45 years old) and is thought to be one of the leading causes of female infertility and the most frequent endocrine problem in women of reproductive age. Principal symptoms of PCOS include anovulation, resulting in irregular menses, amenorrhea, ovulation-related infertility and polycystic ovaries; excessive amounts of androgenic hormones resulting in acne and unwanted facial/body hair growth; and insulin resistance, often associated with obesity, Type 2 diabetes and high cholesterol levels. The symptoms and severity of the syndrome vary greatly among affected women.
"With the introduction of the original Glucorein PCOS over a year ago," said Susan Derence, director of sales for NVN Therapeutics, "thousands of women with PCOS have been provided sustainable relief from their PCOS symptoms without the use of drugs. I continue to receive emails from women who have successfully become pregnant while using Glucorein—women who have tried and repeatedly failed with other fertility treatment modalities. And now, with the new tropical flavor, we provide these women with another flavorful option."
Glucorein™ for PCOS, to be used under the supervision of a medical professional, can be ordered by phoning 1-888-259-6599. Visit the web site at www.nvnth.com/PCOS. Typically, physicians recommend a single serving of Glucorein™ PCOS per day.
About NVN Therapeutics
NVN Therapeutics, a division of Oculus Innovative Sciences (Nasdaq:OCLS), develops and manufactures medical foods, providing natural solutions without compromise. Established in 2011, the company's current focus is the development of medical food to address women's health issues. The company is headquartered in Sacramento, California. More information can be found at www.nvnth.com.
High-resolution product photos are available. Please call or email request.
CONTACT: NVN Therapeutics Dan McFadden Vice President of Marketing (425) 753-2105 email@example.comSource: NVN Therapeutics